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Background
Nasal polyposis (NP) is a multifactorial disorder that is correlated with multiple inflammatory,
environmental, as well as genetic factors. Moreover, tumor necrosis factor (TNF)‑alpha is
regarded as the most prominent pro‑inflammatory cytokine that contributes to the pathogenesis
of NP. Multiple polymorphisms of that gene can influence its function.

Aim

The aim of this study was to detect TNF‑α polymorphism in patients with nasal polypi to
determine its contribution to the pathogenesis of nasal polypi in the Egyptian population.

Methods

This is a case–control study, in which 25 patients with NP as well as 25 healthy participants
were included, who attended Ain Shams University hospital. Participants were examined and
prepared for the study. Participants were subjected to DNA extraction, and restriction fragment
length polymorphism–polymerase chain reaction was administrated to detect polymorphism.
The comparison of the genotype frequency distribution and the TNF‑alpha gene alleles with
NP was done using χ2 test.

Results

The results showed a statistically marked difference between the G/G genotype in the two
groups (P=0.0001). In addition, the presence of allele A in the patient group and control group
was 10 and 1%, respectively, which is statistically significant (P=0.0001). The genotype G/G,
A/A, as well as G/A frequency in the NP group was 8, 40, and 52%, and it was 76, 1, and 5% in
the control group, respectively. The findings of the present study showed that the polymorphism
in TNF‑alpha gene is probably an important NP risk agent in the Egyptian population. The
presence of the TNF‑alpha G308A allele in our study was to some extent higher compared
with the other populations in other previous studies.

Conclusion

According to the scientific evidence for G/A 308 polymorphism related to the promoter of
TNF‑α gene in Egypt, the genotypic pattern distribution in all regions appears to be the same.
Nonetheless, the amount of allele A was higher in the current research than in the control
group, in addition to the incidence of the NP‑associated G/A genotype. However, to obtain
accurate findings, larger samples are required. Regarding the results of the present study,
this polymorphism may be determined as a risk agent for NP susceptibility in relation to the
Egyptian population.
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Introduction
Nasal polyposis (NP) appears to be one of the
most prevailing chronic inflammatory diseases of
the nasal mucosa as well as the sinuses that causes
nasal obstruction. Most patients complain of nasal
obstruction, breathing difficulty, nasal discharge,
posterior nasal drip, nasal congestion, sinus pain,
anosmia, and hyposmia. It is not clear why some people
develop chronic inflammation that causes nasal polyps,
whereas others do not. People with chronic sinus
infections, allergic rhinitis, asthma, and cystic fibrosis
are more likely to develop nasal polyps [1].
During the past 10 years, multiple studies have been
performed to detect the susceptible genes that correlate

with nasal polypi‑related traits. Despite the multiple
contributions to the identification of candidate genes
as well as their association with formation of nasal
polypi, the genetic and molecular modifications that
are required for their evolution and development
remain unclear [2].
Even though several inflammatory cytokines have been
detected in the tissues of the nasal polypi, the primary
trigger, which results in the inflammation associated
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with edema, eosinophilia, as well as lymphocytosis,
remains unidentified [3].
Tumor necrosis factor (TNF‑α) is a strong immune
mediator as well as a pro‑inflammatory cytokine that is
involved in the pathogenesis of several famous diseases.
The presence of this particular gene on the short arm of
chromosome 6 (with major histocompatibility complex
(MHC) genes in addition to complement) resulted
in an increase in the possibility of polymorphism to
contribute to the genetic correlation of this region of
the genome with the nose polyps [4].
Rostkowska et al. [5] investigated the gene‑coding
expression of TNF‑α as well as its receptors
(TNF‑R1 and TNF‑R2) in patients with NP. TNF‑R1
was identified as the predominant form of the TNF‑α
receptor in nasal polyps, thus indicating the evident
prevalence of this type in TNF‑α signaling.These findings
increase the probability that eosinophils induced by NP
can affect the biological responses via the dependent
mechanism of TNF‑α. They proposed that the differences
between eosinophilic nasal polyp and NP associated with
TNFα, and the expression of its receptors is probably a
reflection of the special feature of this disease.

Materials and methods
In our case–control study, 50 participants underwent
blood sampling (25 healthy individuals and 25 patients
with NP). The patients had a referral to an academic
specialist at Ain Shams university, Cairo, between
February 2016 and July 2020. The control group had no
known nasal diseases, whereas the NP group patients
had a history of rhino‑sinusitis and a family history
of NP and allergy. The exclusion criteria were patients
with fungal sinusitis. The study was approved by the
Ethics Committee of Ain Shams University.
Genotyping

(4)		
50 μl of resuspended magnetic beads was
added, followed immediately by 950 μl of
binding buffer 2, and mixed well. Then, the
mixture was incubated at room temperature
for 5 min.
(5)		
The magnetic bead/DNA complex was
separated for 2 min, the supernatant was
discarded, and then the tube was removed from
the chemagic stand 2 × 12 (magnet position).
(6)		The bead pellet was completely resuspended in
800 μl of wash buffer 3.
(7)		
The separation of the magnetic bead/DNA
complex lasted for one minute, and then the
supernatant was left behind.
(8)		The tube was then removed from the magnetic
separator, and the washing procedure was
repeated (Steps 5 and 6) with 800 μl of Wash
Buffer 4, and then with 800 μl of Wash Buffer
5.
(9)		The tube was left in the magnet position.
(10)	When the beads were attracted to the magnet,
1.5 ml of wash buffer number 6 was added and
left for 90 s without resuspending the bead
pellet. The supernatant was carefully removed
and discarded.
(11)	Overall, 200 μl of elution buffer number 7 was
added, and the magnetic bead/DNA complex
was resuspended. It was incubated for ten
minutes at room temperature, with occasional
agitation.
(12)	
The magnetic beads were separated and
transferred to a clean tube.
(13)		The DNA was stored at a temperature of −20°C
till it is used.
Selection and synthesis of oligonucleotides

TNF‑α gene lies in the greatly polymorphic MHC
area on chromosome 6p21.3. The synthetization of the
following primers was done:

The genotyping performed on the specimens involved
the following stages:

Forward primer, 5’‑AGGCAATAGGTTTTGA
GGGCCAT‑3’, and reverse primer, 5’‑TCCTCCCT
GCTCCGATTCCG‑3’ [6].

DNA extraction

Genotyping was performed using ASO‑PCR method
after the expansion of nearly 200 ng genomic DNA
template to a PCR reaction volume of 25 μl, using two
various alleles for one nucleotide polymorphism in one
PCR reaction.

(1)		DNA extraction from 250 μl of blood by the
Chemagic DNA Blood 250 Kit and Chemagic
magnetic stand 2 × 12 (Art. No. CMG‑300)
(Chemagen
Technology,
PerkinElmer,
Baesweiler, Germany) was carried out as follows:
(2)		Lysis buffer in a volume of 350 μl was added
to 250 μl of whole blood. It was vortexed until
a uniform solution was obtained.
(3)		The sample was incubated for 5 min at room
temperature.

The PCR program (S24 thermal cycler™, Quanta
Biotech®, Surrey, England, UK) consisted of
PCR conditions as follows: 5 min at 95°C, then
30 denaturation cycles at 94°C for 30 s, annealing at
60°C for 30 s, as well as expansion for 45 s at 72°C.
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The last extension procedure was carried out for 8 min
at 72°C.
The genotypes of the PCR products for TNF‑α−308
(G/A) polymorphism (107 bp) were defined via
electrophoresis on 2% high‑resolution agarose gels,
and stained with ethidium bromide in 1 × Tris‑EDTA
(ethylenediaminetetraacetic acid).
Then the amplification products were digested with
NcoI restriction enzyme. The existence of a NcoI
restriction site in the TNF‑α (A allele) mutant allele
was demonstrated by the dissent of 107 bp amplicon
to produce 2 fragments of 87 bp as well as 20 bp, and
subsequently was electrophoresed on a 3% agarose gel
stained with ethidium bromide in 1 × Tris‑EDTA.
Comparison of the distribution of the genotypes as
well as frequencies of allele was statistically performed
in healthy controls against the patient group.

Results
With respect to the NP group, there were 11
males and 14 females, and their mean age was
41.8±10.2 years (minimum and maximum 30 and 60
years), whereas in the control group, there were 15
males and 10 females, with a mean age of 30.7±5.9
years (minimum 26 and maximum 69 years). No
statistically significant differences were detected
regarding sex (P=0.258) between the control and the
study groups. In addition, there was no significant
difference concerning age in both groups (P<0. 247),
as shown in Table 1.
A total of 19 controls (76%) had the GG genotype,
whereas just two cases (8%) had this genotype in the
NP group (P=0.0001). Moreover, there was a marked
frequency difference with respect to alleles in both of
the polyps as well as the control groups (P=0.0001). A
total of 13 participants (52%) had the GA genotype,
whereas only five controls (20%) had the GA genotype.
Overall, 10 (40%) had the AA genotype, whereas only
one control (4%) had the AA genotype, as displayed in
Table 2.
According to the relationship between the
TNF‑α‑308G/A
promoter
single‑nucleotide
polymorphism (SNP) genotype as well as the NP
Table 1 Demographic features of controls as well as cases
Variable
Age (years)
Sex (M/F)

Cases (n=25)

Controls (n=25)

P

41.8±10.2

30.7±5.9

<0.247*

11/14

15/10

0.258**

Data are mean±SD or ratio. F, female; M, male. *Unpaired t‑test.
**Pearson χ2 test.

91

phenotype, 33.3% of the GG genotype cases were
antrochoanal, whereas 0% of the GG were unilateral
nasal polyp. Overall, 5.6% had GG bilateral nasal
polyps. Moreover, 0% had an antrochoanal GA,
whereas 75% had a unilateral GA nasal polyp. In
addition, 55.6% had GA bilateral nasal polyps.
Overall, 66.7% had AA antrochoanal, whereas 25%
had AA unilateral nasal polyps. Additionally, 38.9%
had AA bilateral nasal polyps. These results are not
statistically significant (P value=0.201), as displayed
in Table 3.
According to the relationship between TNF‑α‑308G/A
promoter SNP allele segregation and the NP
phenotype, 33.3% of G allele cases were antrochoanal,
whereas 37.5% of G allele cases were unilateral nasal
polyp. Overall, 33.3% of G allele cases were bilateral
nasal polyps. Moreover, 66.7% of A allele cases were
antrochoanal, whereas 62.8% of A allele cases were
unilateral nasal polyp. In addition, 66.7% of A allele
cases were bilateral nasal polyps. These results are not
statistically significant (P value<0.999), as presented in
Table 4.
According to the relationship between sex and
TNF‑α‑308G/A promoter SNP genotype, there
was no statistically significant differences between
males and females regarding genotype in both the
case and the control groups. Overall, there was no
significant differences with respect to alleles, as shown
in Tables 5 and 6.

Discussion
NP is regarded as an inherent inflammatory disease
that affects paranasal sinuses as well as nasal mucosa.
There was an increase in tissue eosinophilia, edema, and
surface epithelial structure [7]. Despite hypothesizing
some etiologic factors such as allergies and fungal
and bacterial infections, as well as some genetic
factors, the actual pathogen of this disease remains
unelucidated [8,9].
TNF‑α is responsible for regulating the receptors
as well as molecules of the endothelial cells of nasal
polyps [7]. The polymorphism of TNF gene can
induce increased risk or severity of occurrence of
NP [10,11]. TNF‑α gene is particularly important
in respiratory tract inflammation, and affects the
permeability of epithelial cell [12]. TNF‑α represents
a member of the pro‑inflammatory cytokine family
and has a synergistic role in the chronic inflammation
process. The expression of adhesion molecules in nasal
polyps is regulated by TNF‑alpha gene by eradicating
eosinophils in lamina propria [13].
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Table 2 Comparison of TNF‑α‑308G/A promoter SNP genotype in cases and controls
Cases (n=25)

Controls (n=25)

P

Homozygote wild (GG)
Heterozygote (GA)

2 (8.0%)
13 (52.0%)

19 (76.0%)
5 (20.0%)

<0.0001*

Homozygote mutant (AA)

10 (40.0%)

1 (4.0%)

TNF‑α‑308G/A promoter SNP genotype

Data are number (%). SNP, single‑nucleotide polymorphism; TNF, tumor necrosis factor. *Pearson χ2 test.
Table 3 The correlation between the TNF‑α‑308G/A promoter SNP genotype as well as the nasal polyposis phenotype
Phenotype of cases
Antrochoanal polyp (n=3)

Unilateral nasal polyp (n=4)

Bilateral nasal polyps (n=18)

P

Homozygote wild (GG)
Heterozygote (GA)

1 (33.3%)
0 (0.0%)

0 (0.0%)
3 (75.0%)

1 (5.6%)
10 (55.6%)

0.201*

Homozygote mutant (AA)

2 (66.7%)

1 (25.0%)

7 (38.9%)

TNF‑α‑308G/A promoter SNP genotype

Data are number (%). SNP, single‑nucleotide polymorphism; TNF, tumor necrosis factor. *Fisher’s exact test.
Table 4 Relation between TNF‑α‑308G/A promoter SNP allele segregation and phenotype of nasal polyposis
Allele

P

Phenotype of cases

TNF‑α‑308G/A promoter SNP allele
G
A

Bilateral

Unilateral

Antrochoanal

12 (33.3%)
24 (66.7%)

3 (37.5%)
5 (62.8%)

2 (33.3%)
4 (66.7%)

36

8

6

Total

>0.999*

Data are number (%). SNP, single‑nucleotide polymorphism; TNF, tumor necrosis factor. *Fisher’s exact test.
Table 5 Relation between sex and TNF‑α‑308G/A promoter SNP genotype
Group
Cases (n=25)

Controls (n=25)

All subjects (n=50)

TNF‑α308 G/A promoter SNP genotype
Homozygote wild (GG)
Heterozygote (GA)
Homozygote mutant (AA)
Group total
Homozygote wild (GG)
Heterozygote (GA)
Homozygote mutant (AA)
Group total
Homozygote wild (GG)
Heterozygote (GA)
Homozygote mutant (AA)
Grand total

Sex

Total

P
0.188*

M

F

2 (18.2%)
4 (36.4%)
5 (45.5%)
11
12 (80.0%)
3 (20.0%)
0 (0.0%)
15
14 (53.8%)
7 (26.9%)
5 (19.2%)

0
9 (64.3%)
5 (35.7%)
14
7 (70.0%)
2 (20.0%)
1 (10.0%)
10
7 (29.2%)
11 (45.8%)
6 (25.0%)

2 (8.0%)
13 (52.0%)
10 (40.0%)
25
19 (76.0%)
5 (20.0%)
1 (4.0%)
25
21 (42.0%)
18 (36.0%)
11 (22.0%)

26

24

50

0.769*

0.198**

Data are number (%). SNP, single‑nucleotide polymorphism; TNF, tumor necrosis factor. *Fisher’s exact test. **Pearson Chi‑squared test.
Table 6 Relation between sex and TNF‑α‑308G/A promoter SNP allele segregation
Group
Cases (n=25)

Controls (n=25)

All subjects (n=50)

TNF‑α‑308G/A promoter SNP allele

Total

P

9 (32.1%)
19 (67.9%)
28
16 (80.0%)
4 (20.0%)
20
25 (52.1%)
23 (48.9%)

17
33
50
43
7
50
60
40

0.773*

48

100

Sex
M

F

G
A
Group total
G
A
Group total
G
A

8 (36.4%)
14 (63.6%)
22
27 (90.0%)
3 (10.0%)
30
35 (67.3%)
17 (32.7%)

Grand total

52

0.416*

0.122**

Data are number (%). SNP, single‑nucleotide polymorphism; TNF, tumor necrosis factor. *Fisher’s exact test. **Pearson χ2 test.

Baikhan et al. [14] illustrated that the existence of
TNF‑α‑308 G/A SNP is a self‑reliant risk agent for
nasal polypi development as well as gene‑transcriptional

activity. In conjunction with the study by Batikhan et al.,
there was a statistically marked correlation between
TNF‑α G/A 308 polymorphism and NP (P=0.0001).
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The findings indicated that G/A genotype 308 patients
experienced 2.6 times greater risk to develop NP,
whereas G/G 308 patients in the TNF‑alpha gene
in the promoter gene experienced a 54% lower risk
to develop NP. Furthermore, the findings of the
current study are consistent with previous studies
that investigated the correlation between TNF‑α
G/A 308 gene polymorphisms and development of
diabetes, NP, and acne [4,15]. Regarding the various
frequencies of SNP marker in different populations,
researchers who have attributed a certain disease or
a specific disorder association with the same SNP
are argumentative. Consequently, every population
study has value in relation to the field of personalized
medicine; nonetheless, the G308A allele frequency
in the Egyptian population is somewhat contrasting
when compared with other populations.
When comparing the frequency of G308A minor
allele in 5 various populations, their data are available
via databases of Ensemble; there is a lower frequency
of allele G308A variant in European, African, South
Asian, American, as well as East Asian is 13, 12, 5, 7,
and 6%, respectively. Although this frequency is 20% in
the current study, there is no significant deviation from
Hardy–Weinberg equilibrium in such populations. As
illustrated earlier, the lower frequency of G308A allele
in this study is slightly higher compared with other
major populations.
In the current study, the male patients were roughly
equal to females and patients’ age ranged from 16 to
69 years in all age groups; this can be attributed to the
small sample size (25 patients).
The occurrence of NP in males was approximately equal
in females (51% and 49%, respectively). Bernstein and
his research team did not confirm these results [4,16].
They demonstrated that chemicals, occupational
exposure, as well as smoking in males are probably
responsible for such differences. Furthermore, the study
results were inconsistent with Busaba and his research
team, as they stated marked differences regarding the
association between chronic rhinosinusitis and NP
and sex. Moreover, those males had more tendency to
experience chronic rhinosinusitis with NP [17]. With
respect to the examination, eosinophils are estimated to
be approximately 80% of inflammatory cells; moreover,
they proliferate in the nasal polyps [7].
TNF‑α stimulates the production of vascular cell
adhesion molecule 1 (VCAM‑1); moreover, increasing
the VCAM‑1 production results in more eosinophil
migration into nasal polyps. In contrast, the increase
of eosinophils in the tissues of nasal polyp produces
more TNF‑α, which consequently brings large
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amounts of eosinophils into the polyp mucosa [4,18].
Based on the current results, it was found that A allele
TNF‑α 308 gene was greater in patients with NP
compared with the control group (P=0.0001), and the
A allele was known to be mutated at 107 bp, which
is associated with the TNF‑α gene transcription [19].
Berghea and Szabo found no correlation between
the allelic frequency of TNF‑α 308 G/A among
Romanians [3] as well as Hungarians [9], which
contradicts the present study, owing to the reason that
their research is concerned with patients with chronic
rhino‑sinusitis, asthmatics, as well as patients with
aspirin sensitivity; nonetheless, their research was not
concerned with patients with nasal polypi.
Furthermore, Berghea et al. [3] only enrolled
45 patients, and they proposed multicenter studies
as well as collaborative studies for more precise
interpretation. After accurate stratification of the
patient group based on observing the clinical symptoms,
Szabo concluded that there is a marked higher rate of
transmitting rare A allele that contain genotypes in
patients with chronic rhinosinusitis with NP, who were
sensitive to aspirin as well [9].
The results of the current study also indicated that age
is regarded as a risk factor for NP in TNF‑α promoter
gene G/A 308 genotype patients, which aligns with
the findings of previous studies that demonstrated that
the occurrence as well as the prevalence of nasal polyps
increases with age, particularly between the ages of 40
and 60 years [20,21].
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